Longboard Pharmaceuticals, Inc. (LBPH) - Quarterly Income Statement

Home
LBPH
Financials

29.31 (USD) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0.008	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.002	0.001	0.001	0.001	0.002	0.001	0.001	0.001	0.002	0.001	0.001	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	-0.002	-0.001	0.007	-0.001	-0.002	-0.001	-0.001	-0.001	-0.002	-0.001	-0.001	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.875	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	20.445	13.17	12.198	10.488	12.536	8.53	9.193	9.403	8.921	7.121	6.368	4.093	4.915	4.398	2.171	1.603	0.8	0.059
General & Administrative Expenses Numbers are in millions	5.198	4.94	3.375	3.094	3.106	3.432	2.534	2.481	2.646	2.499	2.426	2.262	2.072	1.305	7.938	0.947	0.767	0.115
Selling & Marketing Expenses Numbers are in millions	0	-0.001	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	5.198	4.939	3.375	3.094	3.106	3.432	2.534	2.481	2.646	2.499	2.426	2.262	2.072	1.305	7.938	0.947	0.767	0.115
Other Expenses Numbers are in millions	0	-0.009	-0.027	-0.014	-0.017	-0.01	-0.009	0.001	0.033	-0.009	-0.003	-0.013	-0.006	0	0	0	0	0
Operating Expenses Numbers are in millions	25.643	18.109	15.573	13.582	15.642	11.962	11.727	11.884	11.567	9.62	8.794	6.355	6.987	5.703	10.109	2.55	1.567	0.174
Operating Income Numbers are in millions	-25.643	-18.11	-15.573	-13.582	-15.642	-11.962	-11.727	-11.884	-11.567	-9.62	-8.794	-6.355	-6.987	-5.703	-10.109	-2.55	-1.567	-0.174
Operating Income Ratio Numbers are in millions	0	0	-1,946.625	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	3.858	3.124	-0.027	0.648	-0.017	0.506	0.382	0.288	0.033	-0.009	-0.003	-0.013	-0.006	0.004	-7.4	0	0	0
Income Before Tax Numbers are in millions	-21.785	-14.986	-15.033	-12.934	-14.999	-11.456	-11.345	-11.596	-11.407	-9.597	-8.773	-6.345	-6.98	-5.699	-10.109	-2.55	-1.567	-0.174
Income Before Tax Ratio Numbers are in millions	0	0	-1,879.125	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	-0.002	-0.042	-0.567	-0.001	-0.66	-0.506	-0.382	-0.288	-0.127	-0.032	-0.025	-6.378	-7	-5.703	-10.109	-2.55	-1.567	-0.174
Net Income Numbers are in millions	-21.785	-14.986	-15.033	-12.934	-14.999	-10.95	-10.963	-11.308	-11.407	-9.597	-8.773	-6.345	-6.98	-5.699	-10.109	-2.55	-1.567	-0.174
Net Income Ratio Numbers are in millions	0	0	-1,879.125	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.56	-0.42	-0.63	-0.55	-0.65	-0.54	-0.64	-0.66	-0.67	-0.56	-0.52	-0.38	-0.41	-0.84	-0.6	-0.15	-0.093	-0.01
EPS Diluted Numbers are in millions	-0.56	-0.42	-0.63	-0.55	-0.65	-0.54	-0.64	-0.66	-0.67	-0.56	-0.52	-0.38	-0.41	-0.84	-0.6	-0.15	-0.093	-0.01
EBITDA Numbers are in millions	-25.643	-18.109	-15.572	-13.582	-15.64	-11.962	-11.726	-11.883	-11.565	-9.619	-8.794	-6.355	-6.987	-5.703	-10.109	-2.55	-1.567	-0.174
EBITDA Ratio Numbers are in millions	0	0	-1,946.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Longboard Pharmaceuticals, Inc.

NASDAQ:LBPH Add to watchlist

NASDAQ:LBPH